The biggest mistake people make when trying to get their ChatGPT API key is that they use the wrong URL. The key can't be found at chatgpt.com. Instead, point your browser to the OpenAI developer ...

Microsoft and OpenAI have dismantled their exclusive partnership, ending revenue sharing and freeing OpenAI to sell its AI ...

Anthropic said its annualized revenue has grown to $30 billion, in a sign of its rapidly evolving financial fortunes Anthropic's revenue run rate has hit $30 billion, a massive jump from the $9 ...

OpenAI told investors this week that its early push to dramatically increase computing resources gives it a key advantage over Anthropic PBC at a moment when its longtime rival is gaining ground and ...

Bill Peebles, who led OpenAI's defunct short-form video app Sora, and Kevin Weil, the vice president of OpenAI for Science, announced their departures on Friday. Srinivas Narayanan, who worked in B2B ...

A flaw in Google's API key system has reportedly exposed mobile applications to unintended access to its Gemini AI platform. According to a CloudSEK advisory published on April 8, the issue affects ...

Microsoft Takes Over Key Stargate Site in Latest OpenAI Pullback Your email has been sent Microsoft has taken over the commitment to rent data center capacity at a site in Norway, originally intended ...

Disney is taking a bold step into the AI era — and letting fans play with some of its most famous characters in a way never seen before. The entertainment giant has struck a landmark deal with OpenAI ...

April 21 - Amazon (AMZN.O), opens new tab said it will invest up to $25 billion in Anthropic, as the AI startup commits to spending more than $100 billion over the next 10 years on Amazon's cloud ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized. Scientists at Scripps Research have discovered ...

Dysregulated TREM-1 activation is increasingly implicated in both acute and chronic inflammatory conditions, yet effective targeted therapies remain limited." Nesrine S. El Sayed, corresponding author ...